Gemcitabine plus etoposide in chemonaive extensive disease small-cell lung cancer: a multi-centre phase II study.

Vansteenkiste, J; Gatzemeier, U; Manegold, C; Hanauske, A; Weynants, P; Bosquée, L; Blatter, J; Mansouri, K; von Pawel, J

Vansteenkiste, J; Gatzemeier, U; Manegold, C; Hanauske, A; Weynants, P; Bosquée, L; Blatter, J; Mansouri, K; von Pawel, J.

Affiliation

Vansteenkiste J; Respiratory Oncology Unit, Univ. Hosp. Gasthuisberg, Leuven, Belgium. johan.vansteenkiste@uz.kuleuven.ac.be

Ann Oncol ; 12(6): 835-40, 2001 Jun.

Article in En | MEDLINE | ID: mdl-11484961

Subject(s)

Antineoplastic Combined Chemotherapy Protocols/administration & dosage; Carcinoma, Small Cell/drug therapy; Deoxycytidine/analogs & derivatives; Deoxycytidine/administration & dosage; Etoposide/administration & dosage; Lung Neoplasms/drug therapy; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols/adverse effects; Carcinoma, Small Cell/pathology; Carcinoma, Small Cell/secondary; Deoxycytidine/adverse effects; Etoposide/adverse effects; Female; Humans; Infusions, Intravenous; Lung Neoplasms/pathology; Lung Neoplasms/secondary; Male; Middle Aged; Survival Analysis; Treatment Outcome; Gemcitabine

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Antineoplastic Combined Chemotherapy Protocols / Carcinoma, Small Cell / Deoxycytidine / Etoposide / Lung Neoplasms Type of study: Clinical_trials / Guideline Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Ann Oncol Year: 2001 Document type: Article

Search on Google

XML

PubMed Links